Inventor · disambiguated record
Jochen Huber
Also filed as: HUBER JOCHEN
9 granted patents·2 pending applications·97 citations·filing 2002–2023
86Inventor score
Files withSANOFI AVENTIS DEUTSCHLAND4BOEHRINGER INGELHEIM INT2AVENTIS PHARMA GMBH1HUBER JOCHEN1SANOFI AVENTIS1
Top patents by PatentIndex Score
11 records- 0185US11690848B2Alkoxy pyrazoles as soluble guanylate cyclase activatorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Jul 4, 2023·4 cites·13 claims
- 0285US7169612B2Use of EDG2 receptor in an animal model of heart failureSANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted Jan 30, 2007·34 cites·7 claims
- 0384US7635769B2Oligoribonucleotide derivatives for specific inhibition of gene expressionSANOFI AVENTIS DEUTSCHLAND·Filed 2005·Granted Dec 22, 2009·9 cites·21 claims
- 0483US7279286B2High-throughput-assay with high sensitivity for measuring of the activity of β-adrenergic receptor kinase and for determining the impact of test substances on such activitySANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Oct 9, 2007·23 cites·19 claims
- 0582US8772469B2Synthetic double-stranded oligonucleotides for specific inhibition of gene expressionUHLMANN EUGEN·Filed 2002·Granted Jul 8, 2014·26 cites·25 claims
- 0663US6930103B2Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseasesAVENTIS PHARMA GMBH·Filed 2003·Granted Aug 16, 2005·1 cites·15 claims
- 0758US12226411B2Soluble guanylate cyclase activators for treating portal hypertensionBOEHRINGER INGELHEIM INT·Filed 2023·Granted Feb 18, 2025·0 cites·13 claims
- 0851US7514423B2Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseasesSANOFI AVENTIS DEUTSCHLAND·Filed 2005·Granted Apr 7, 2009·0 cites·8 claims
- 0946US7910602B2Pyrazolopyridine derivatives as inhibitors of β-Adrenergic receptor kinase 1SANOFI AVENTIS·Filed 2007·Granted Mar 22, 2011·0 cites·14 claims
- 1044US2003105052A1Oligoribonucleotide derivatives for specific inhibition of gene expressionFiled 2002·Application pending·0 cites
- 1132US2012282637A1Polypeptides for binding to the receptor for advanced glycation endproducts as well as compositions and methods involvingHUBER JOCHEN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jochen Huber files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →